- Home
- VBF vs DERM Comparison
VBF vs DERM Comparison
Compare VBF & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VBF
- DERM
- Stock Information
- Founded
- VBF 1970
- DERM 2014
- Country
- VBF United States
- DERM United States
- Employees
- VBF N/A
- DERM N/A
- Industry
- VBF Trusts Except Educational Religious and Charitable
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- VBF Finance
- DERM Health Care
- Exchange
- VBF Nasdaq
- DERM Nasdaq
- Market Cap
- VBF 172.3M
- DERM 140.0M
- IPO Year
- VBF N/A
- DERM 2021
- Fundamental
- Price
- VBF $14.95
- DERM $6.25
- Analyst Decision
- VBF
- DERM Strong Buy
- Analyst Count
- VBF 0
- DERM 2
- Target Price
- VBF N/A
- DERM $10.00
- AVG Volume (30 Days)
- VBF 45.5K
- DERM 103.6K
- Earning Date
- VBF 01-01-0001
- DERM 05-12-2025
- Dividend Yield
- VBF 5.18%
- DERM N/A
- EPS Growth
- VBF N/A
- DERM N/A
- EPS
- VBF N/A
- DERM N/A
- Revenue
- VBF N/A
- DERM $56,134,000.00
- Revenue This Year
- VBF N/A
- DERM $29.83
- Revenue Next Year
- VBF N/A
- DERM $54.88
- P/E Ratio
- VBF N/A
- DERM N/A
- Revenue Growth
- VBF N/A
- DERM N/A
- 52 Week Low
- VBF $13.68
- DERM $3.20
- 52 Week High
- VBF $16.27
- DERM $7.29
- Technical
- Relative Strength Index (RSI)
- VBF 40.11
- DERM 53.65
- Support Level
- VBF $14.87
- DERM $5.98
- Resistance Level
- VBF $15.08
- DERM $6.40
- Average True Range (ATR)
- VBF 0.30
- DERM 0.62
- MACD
- VBF -0.02
- DERM -0.06
- Stochastic Oscillator
- VBF 47.33
- DERM 36.97
About VBF Invesco Bond Fund
Invesco Bond Fund is an independent investment management firm. Its investment objective is to seek interest income while conserving capital.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.